Gastroenterology Market Size, Share, Growth Analysis, By Drug Type(Antacids, Laxatives, Antidiarrheal agents, Antiemetics), By Dosage Form(Oral, Parenteral, Other Dosage Forms), By Application(Ulcerative Colitis, Irritable Bowel Syndrome, Crohn's Disease, Celiac Disease), By Region - Industry Forecast 2024-2031

Based on the region, the North American region currently dominates the global gastroenterology market. The market in North America had the biggest share in 2021 and is anticipated to hold that position during the projected period. Technological advancements, an unprecedented change in lifestyle leading to a higher incidence of gastrointestinal diseases, an increase in the number of geriatric and obese people, and rising research and development activities with the presence of key market players are some of the factors that are fueling the market growth in the North American region. Additionally, the government's measures to prevent and treat gastrointestinal disorders are anticipated to propel the market. For instance, UNICEF and WHO's Integrated Global Action Plan for Diarrhea aims to reduce the number of child deaths that can be prevented due to diarrhea by providing interventions and services to increase awareness and offer access to treatment and preventative measures.

Asia Pacific is expected to increase at an exponential rate over the projection period. Consistent efforts made by important stakeholders, including expenditures in R&D and the launch of branded medications at a relatively lower cost, are anticipated to fuel this. Additionally, it is anticipated that over the course of the projection period, the regional market would provide high potential growth possibilities due to the urgent need to reduce the high incidence rate of gastrointestinal illnesses and technological upgrades to the healthcare infrastructure.